Foundation for Advanced Cardiovascular Education and Training Dallas CV Updates 2026

• Target Audience: cardiologists, vascular surgeons, and electrophysiologists
• Sample video: contact me for sample video
• Information:

1. Overview

The Dallas CV Updates 2026, hosted by the Foundation for Advanced Cardiovascular Education and Training (FACET), took place on February 21, 2026. The conference highlighted the latest advancements in cardiology, focusing on congestive heart failure, coronary artery disease, pulmonary hypertension, and structural heart issues.

2. Learning Objectives

Evaluate and implement endovascular and surgical interventions for vascular conditions, including Thoracic Outlet Syndrome, Renal Artery Stenosis, and Chronic Limb-Threatening Ischemia.

Optimize lipid management in Coronary Artery Disease using Lipoprotein A and Apolipoprotein B, and utilize advanced imaging like Coronary CTA and FFR.

Assess the latest techniques in structural heart and valve interventions, including TAVR, mitral innovations (robotics/transcatheter), and tricuspid advances.

Apply updated strategies for arrhythmia management, comparing pulse field ablation, hybrid surgical-catheter approaches, and device-detected AFib anticoagulation.

Integrate new heart failure trial data and evaluate the indications for advanced therapies, including Barostim and cardiac contractility modulation.

3. Target Audience

Best for cardiologists, vascular surgeons, and electrophysiologists who want updates on structural heart interventions, CAD, and arrhythmias.

4. Topics

01 Thoracic Outlet Syndrome- A ‘Pressing’ Diagnosis to Consider in Upper Extremity Heaviness and Swelling with Strenuous Activity

02 Renal Artery Stenosis When to Consider Endovascular Intervention

03 Iliac Vein Compression To Stent or Not to Stent That is the Question

04 Chronic Limb-Threatening Ischemia When Endovascular and Surgical Options Can’t Play…Can Deep Vein Arterialization Save the Day

05 Role of Lipoprotein A and Apolipoprotein B in Management of Lipid Optimization in Patients with Coronary Artery Disease

06 Invasive Assessment and Management of Microvascular Dysfunction in Patients with Angina and Normal or Non-Obstructive CAD

07 Role of Coronary CTA and Coronary CTA FFR in the Diagnosis and Management of CAD

08 Utilization of Minimally Invasive LIMA and Multi-Arterial Conduit Bypass Grafts in Coronary Artery Bypass Surgery

09 Safer, Faster, But Is It Better Clinical Outcomes with Pulse Field Ablation for Atrial Fibrillation

11 Smart Detection, Smarter Protection Anticoagulation for Device-Detected New Onset Atrial Fibrillation

12 When the Heart Needs a Boost Understanding Cardiac Contractility Devices for Frontline Clinicians

13 Management of Asymptomatic High-Burden PVCs The Case For and Against Catheter Ablation

14 Rediscovering the Forgotten Valve Advances in Tricuspid Intervention

15 Mitral Innovation Port Access, Robotics, and Transcatheter Breakthroughs

16 The Quiet Threat Severe Aortic Stenosis Without Symptoms

17 Presentation 1 HF Trial Data and Outcomes

18 Presentation 2 When to Get Advanced Heart Failure Involved

19 Presentation 3 Data for Barostim and Cardiac Contractility Modulation Therapy

20 Presentation 4 When Advanced Therapy is Needed

21 LIVE CASE CAD

22 LIVE CASE STRUCTURAL HEART

Bonus Complex Structural Heart Disease- Advancing TAVR With Electrosurgery and SESAME Techniques

Bonus Persistent and Refractory AFib- When to Use Hybrid Epicardial-Endocardial Ablation

Bonus Vascular Disease Updates From Dallas CV 2026- Carotid Stenting, CLTI, and PE Innovations

Bonus Women’s Cardiovascular Disease Across the Lifespan- From Pregnancy Risk to Menopause Management